Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers.

MLA

Dai, Xiaoshu, et al. “Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers.” Clinical Pharmacology in Drug Development, vol. 10, no. 8, Aug. 2021, pp. 824–39. EBSCOhost, https://doi.org/10.1002/cpdd.961.

APA

Dai, X., Karol, M. D., Hitron, M., Hard, M. L., Goulet, M. T., McLaughlin, C. F., & Brantley, S. J. (2021). Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers. Clinical Pharmacology in Drug Development, 10(8), 824–839. https://doi.org/10.1002/cpdd.961

Chicago

Dai, Xiaoshu, Michael D. Karol, Matthew Hitron, Marjie L. Hard, Matthew T. Goulet, Colleen F. McLaughlin, and Scott J. Brantley. 2021. “Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers.” Clinical Pharmacology in Drug Development 10 (8): 824–39. doi:10.1002/cpdd.961.